MARCUS FELDPAUSCH: Open Payments
NPI 1942759295 · OVID, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 22 payments from 9 companies in 2025. Trend: 2023 $224 · 2024 $485 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Novo Nordisk Inc | 4 | $82 |
| Lilly USA, LLC | 4 | $74 |
| Amgen Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $21 |
| Alvogen Inc | 1 | $20 |
| Radius Health, Inc. | 1 | $18 |
Products named: CAPLYTA, MOUNJARO, Auvelity, Wegovy, EVENITY, REXULTI, Ozempic, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
